MedPacto, Inc. (KOSDAQ:235980)
South Korea · Delayed Price · Currency is KRW 5,650.00
-220.00 (-3.75%)
At close: Feb 6, 2026
MedPacto Company Description
MedPacto, Inc. engages in the development and sale of marker-based new drugs in South Korea. MedPacto, Inc. was established in 2013 and is based in Seoul, South Korea.
MedPacto, Inc.
| Country | South Korea |
| Founded | 2013 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Seong-Jin Kim |
Contact Details
Address: Borim Building Seoul South Korea | |
| Phone | 82 2 6938 0200 |
| Website | medpacto.com |
Stock Details
| Ticker Symbol | 235980 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7235980000 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Seong-Jin Kim | Chief Executive Officer |